A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,600,000 shares of VIGL stock, worth $2.72 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,600,000
Previous 1,485,000 7.74%
Holding current value
$2.72 Million
Previous $5.94 Million 8.42%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.92 - $4.65 $335,800 - $534,750
115,000 Added 7.74%
1,600,000 $5.44 Million
Q2 2024

Aug 14, 2024

BUY
$2.51 - $4.66 $3.73 Million - $6.92 Million
1,485,000 New
1,485,000 $5.94 Million

Others Institutions Holding VIGL

About Vigil Neuroscience, Inc.


  • Ticker VIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,268,600
  • Market Cap $48.1M
  • Description
  • Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...
More about VIGL
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.